FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

246811000001105: Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17150901000001119 Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17151001000001111 Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Is a Product containing precisely baclofen 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Has active ingredient Baclofen false Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Is a Baclospas true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Has specific active ingredient Baclofen true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) 84 tablet Is pack of False Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) 84 tablet Has AMP True Baclospas 10mg tablets (Ashbourne Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start